hotspot -WSS

hotspot

author：knowledge 2025-09-30 14:58:09 - browse：13659

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： The Affordable Care Act has saved billions in health care costs

knowledge

WSS

Why you shouldn’t ask, “What country has the best health care?”

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Dexcom's push to bring CGM to type 2 diabetes patients

A letter from the executive editor: The 2023 STATUS List

UpToDate has a racism problem: Dr. Stanley Goldfarb

The biotech scorecard for Q3: 15 stock

entertainment

hotspot

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Security flaws in third

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

How one medical school became remarkably diverse

FTC sues over Novant Health acquisition of two N.C. hospitals

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Zyn nicotine pouches become unlikely player in latest culture war

How to save PrEP access — and even expand it

Wegovy leads to weight loss. Can it treat depression, too?

Wikipedia

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

FTC sues over Novant Health acquisition of two N.C. hospitals

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Skip the lead apron during X

Humana’s losses in Medicare Advantage tank its stock

AstraZeneca lung cancer study comes in below expectations

leisure time

entertainment

knowledge

Wikipedia